Literature DB >> 12429297

Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.

Charles Y C Pak1, John R Poindexter, Roy D Peterson, Janice Koska, Khashayar Sakhaee.   

Abstract

OBJECTIVES: To determine whether the biochemical presentation and urinary physicochemical environment of patients with hyperuricosuria presenting with calcium stones (hyperuricosuric calcium urolithiasis [HUCU]) differs from those of patients with gouty diathesis (GD) or idiopathic uric acid urolithiasis.
METHODS: A total of 122 patients with HUCU and 68 patients with GD were identified from our "stone registry" of patients who underwent a full ambulatory evaluation. All patients with HUCU had urinary uric acid greater than 800 mg/day in men and greater than 750 mg/day in women and presented with calcium stones. Those with GD had pure uric acid stones or mixed uric acid-calcium stones and did not have secondary causes of uric acid urolithiasis. Data derived from the fasting serum and 24-hour urine samples collected on a random diet and on a diet restricted in calcium, sodium, and oxalate were compared between the two groups.
RESULTS: Compared with patients with HUCU, those with GD had significantly higher serum uric acid and lower urinary uric acid and pH levels (mean value 5.38 and 5.35 on random and restricted diets versus 6.09 and 6.14, respectively). The fractional excretion of urate and the discriminant score of the relationship between urinary pH and the fractional excretion of urate were significantly lower in those with GD than in those with HUCU. Patients with HUCU displayed a greater urinary saturation of sodium urate and calcium oxalate compared with those with GD, and those with GD had a higher urinary content of undissociated uric acid and lower urinary saturation of brushite (calcium phosphate).
CONCLUSIONS: Patients with HUCU presented with normal urinary pH and hyperuricosuria, accompanied sometimes by hypercalciuria, which produced increased urinary saturation of sodium urate and calcium oxalate. In contrast, those with GD had a low fractional excretion of urate (that contributed to hyperuricemia) and low urinary pH (that led to increased amount of undissociated uric acid). The varying biochemical and physicochemical presentations of the two conditions can be ascribed to overindulgence with purine-rich foods in those with HUCU and underlying primary gout in those with GD.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2002        PMID: 12429297     DOI: 10.1016/s0090-4295(02)01908-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  16 in total

Review 1.  Nephrolithiasis.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

2.  Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.

Authors:  Michael R Wiederkehr; Orson W Moe
Journal:  Clin Rev Bone Miner Metab       Date:  2011-12

3.  Biochemical diagnosis in 3040 kidney stone formers in Argentina.

Authors:  Francisco Rodolfo Spivacow; Elisa Elena del Valle; Armando Luis Negri; Erich Fradinger; Anabella Abib; Paula Rey
Journal:  Urolithiasis       Date:  2015-05-10       Impact factor: 3.436

4.  Calcium oxalate stone and gout.

Authors:  Y M Fazil Marickar
Journal:  Urol Res       Date:  2009-09-25

5.  Uric Acid nephrolithiasis: recent progress and future directions.

Authors:  Tin C Ngo; Dean G Assimos
Journal:  Rev Urol       Date:  2007

6.  Characterisation of risk factors for stones in hyperuricosuric men attending a stone clinic.

Authors:  Valerie Walker; Paul Cook; Damian G Griffin
Journal:  Urolithiasis       Date:  2014-06-04       Impact factor: 3.436

7.  Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.

Authors:  Daniel Hill-McManus; Elena Soto; Scott Marshall; Steven Lane; Dyfrig Hughes
Journal:  Br J Clin Pharmacol       Date:  2017-10-10       Impact factor: 4.335

8.  Influence of body size on urinary stone composition in men and women.

Authors:  Michel Daudon; Bernard Lacour; Paul Jungers
Journal:  Urol Res       Date:  2006-02-11

9.  Diabetes and nephrolithiasis.

Authors:  Michel Daudon; Paul Jungers
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

Review 10.  Uric acid nephrolithiasis.

Authors:  Scott E Liebman; Jeremy G Taylor; David A Bushinsky
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.